Stem cell co Mesoblast reports PhIII trial success in children with GVHD
An Australian stem cell company tackling a disease that often befalls blood cancer patients says it’s met the primary endpoint of a Phase III trial …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
